LMCD1 Polyclonal Antibody, Cy5 Conjugated
Product Specifications
Background
Transcriptional cofactor that restricts GATA6 function by inhibiting DNA-binding, resulting in repression of GATA6 transcriptional activation of downstream target genes. Represses GATA6-mediated trans activation of lung- and cardiac tissue-specific promoters. Inhibits DNA-binding by GATA4 and GATA1 to the cTNC promoter (By similarity) . Plays a critical role in the development of cardiac hypertrophy via activation of calcineurin/nuclear factor of activated T cells signaling pathway.
Synonyms
Dyxin; LIM and cysteine rich domains 1; LIM and cysteine rich domains protein 1; LIM and cysteine-rich domains protein 1; LMCD1_HUMAN.
Cellular Locus
Cytoplasm, Nucleus
Host
Rabbit
Immunogen
51-160/365
Target
LMCD1
Clonality
Polyclonal
Isotype
IgG
Conjugation
Cy5
Source
KLH conjugated synthetic peptide derived from human LMCD1
Applications
WB, IF (IHC-P), IF (IHC-F), IF (ICC)
Purification
Purified by Protein A.
Excitation Emission
625,650nm/670nm
Concentration
1µg/µl
Dilution
WB (1:300-5000), IF (IHC-P) (1:50-200), IF (IHC-F) (1:50-200), IF (ICC) (1:50-200)
Buffer
Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Modification
Unmodified
Storage Conditions
Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
Predicted Cross Reactivity
Human, Dog, Cow, Sheep, Pig, Horse, Rabbit
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1051259-01 0.05 mg (E-Coli)
Recombinant Periplaneta australasiae Pyrokinin-4
Sign In for Pricing
View Details MBS1051259-02 0.2 mg (E-Coli)
Recombinant Periplaneta australasiae Pyrokinin-4
Sign In for Pricing
View Details